EX-99.77E LEGAL

     The Adviser and certain affiliates of the Adviser are
named as defendants in a derivative suit which additionally
names as defendants certain individual trustees of certain
Van Kampen funds.  The named investment companies, including
the Fund, are listed as nominal defendants.  The complaint
alleges that defendants caused the Van Kampen funds to pay
economic incentives to a proprietary sales force to promote
the sale of Van Kampen funds.  The complaint also alleges
that the Van Kampen funds paid excessive commissions to
Morgan Stanley and its affiliates in connection with the
sales of the funds. The complaint seeks, among other things,
the removal of the current trustees of the funds, rescission
of the management contracts for the funds, disgorgement of
profits by Morgan Stanley and its affiliates and monetary
damages. This derivative action was coordinated with a
direct action alleging related violations of defendants'
statutory disclosure obligations and fiduciary duties with
respect to the payments described above.  In addition, this
derivative action was stayed by agreement of the parties
pending rulings on the motion to dismiss the direct action
and the motion to dismiss the action described in the next
paragraph.  In April 2006, the court granted defendants'
motion to dismiss the direct action.  In June 2006, the
court granted defendants' motion to dismiss the action
described in the next paragraph.  Accordingly, the stay on
this action was lifted.  Plaintiff and defendants have
agreed that this action should be dismissed in light of the
rulings dismissing the two cases discussed above.
     The derivative plaintiff in the action described in the
preceding paragraph filed a separate derivative action
against the Adviser, certain affiliates of the Adviser, the
individual trustees of certain Van Kampen funds, and certain
unaffiliated entities.  The named investment companies,
including the Fund, were listed as nominal defendants.  The
complaint alleged that certain unaffiliated entities engaged
in or facilitated market timing and late trading in the Van
Kampen funds, and that the Adviser, certain affiliates of
the Adviser, and the trustees failed to prevent and/or
detect such market timing and late trading.  The complaint
sought, among other things, the removal of the current
trustees of the funds, rescission of the management
contracts and distribution plans for the funds, disgorgement
of fees and profits from the Adviser and its affiliates, and
monetary damages.  The court initially granted in part and
denied in part defendants' motion to dismiss this complaint.
The defendants moved the court to reconsider those claims it
denied.  The plaintiff thereafter voluntarily dismissed the
independent trustees from the action without prejudice.  On
June 14, 2006, the court entered an order granting
defendants' motion for reconsideration and dismissing all
claims in the action.

EX-99.77B ACCT LTTR

Report of Independent Registered Public Accounting Firm


To the Shareholders and
Board of Trustees of the Van Kampen Reserve Fund

In planning and performing our audit of the financial statements of the Van
Kampen Reserve Fund as of and for the year ended May 31, 2006, in accordance
with the standards of the Public Company Accounting Oversight Board (United
States), we considered its internal control over financial reporting,
including control activities for safeguarding securities, as a basis for
designing our auditing procedures for the purpose of expressing our opinion
on the financial statements and to comply with the requirements of Form N-
SAR, but not for the purpose of expressing an opinion on the effectiveness of
the Van Kampen Reserve Fund's internal control over financial reporting.
Accordingly, we express no such opinion.

The management of the Van Kampen Reserve Fund is responsible for establishing
and maintaining effective internal control over financial reporting. In
fulfilling this responsibility, estimates and judgments by management are
required to assess the expected benefits and related costs of controls. A
company's internal control over financial reporting is a process designed to
provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in
accordance with generally accepted accounting principles. Such internal
control includes policies and procedures that provide reasonable assurance
regarding prevention or timely detection of unauthorized acquisition, use or
disposition of a company's assets that could have a material effect on the
financial statements.

Because of its inherent limitations, internal control over financial
reporting may not prevent or detect misstatements. Also, projections of any
evaluation of effectiveness to future periods are subject to the risk that
controls may become inadequate because of changes in conditions, or that the
degree of compliance with the policies or procedures may deteriorate.

A control deficiency exists when the design or operation of a control does
not allow management or employees, in the normal course of performing their
assigned functions, to prevent or detect misstatements on a timely basis. A
significant deficiency is a control deficiency, or combination of control
deficiencies, that adversely affects the company's ability to initiate,
authorize, record, process or report external financial data reliably in
accordance with generally accepted accounting principles such that there is
more than a remote likelihood that a misstatement of the company's annual or
interim financial statements that is more than inconsequential will not be
prevented or detected. A material weakness is a significant deficiency, or
combination of significant deficiencies, that results in more than a remote
likelihood that a material misstatement of the annual or interim financial
statements will not be prevented or detected.



Our consideration of the Van Kampen Reserve Fund's internal control over
financial reporting was for the limited purpose described in the first
paragraph and would not necessarily disclose all deficiencies in internal
control that might be significant deficiencies or material weaknesses under
standards established by the Public Company Accounting Oversight Board
(United States). However, we noted no deficiencies in the Van Kampen Reserve
Fund's internal control over financial reporting and its operation, including
controls for safeguarding securities, that we consider to be a material
weakness as defined above as of May 31, 2006.

This report is intended solely for the information and use of management and
the Board of Trustees of the Van Kampen Reserve Fund and the Securities and
Exchange Commission and is not intended to be and should not be used by
anyone other than these specified parties.


	/s/ ERNST & YOUNG LLP


Chicago, Illinois
July 14, 2006